Document Detail


Immunologic alterations and active aspecific immunotherapy in lung cancer patients.
MedLine Citation:
PMID:  6195126     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An immunologic study was undertaken on 89 lung cancer patients and on the basis of results obtained so far, a protocol of active, aspecific immunotherapy by living bacterial vaccines (BCG) and/or synthetic immunopotentiator (methisoprinol) was carried out. First results obtained in patients undergoing immunostimulation are reported together with the observation that while positive humoral effects seem present in stage I and II patients, in cases of spread of the disease results are substantially negative.
Authors:
P Banna; R Murabito; A Saggio; F Cordopatri; M Riggi; M E Campo; C Cinà; S Latteri
Related Documents :
18932026 - Characteristics of lung cancer patients with asbestos-related radiological findings.
16685016 - The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleur...
18668536 - Treatment of pulmonary fibrosis for twenty weeks with imatinib mesylate in a patient wi...
8180446 - Clinical characteristics of idiopathic interstitial pneumonia (iip) with bullae.
21193056 - Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after al...
598056 - Folic acid status of patients with chronic renal failure maintained by dialysis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Italian journal of surgical sciences / sponsored by Società italiana di chirurgia     Volume:  13     ISSN:  0392-3525     ISO Abbreviation:  Ital J Surg Sci     Publication Date:  1983  
Date Detail:
Created Date:  1983-12-20     Completed Date:  1983-12-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8213451     Medline TA:  Ital J Surg Sci     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  133-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / therapy*
Adult
BCG Vaccine / therapeutic use*
Carcinoma, Small Cell / therapy*
Carcinoma, Squamous Cell / therapy*
Humans
Immunoglobulins / analysis
Immunotherapy
Inosine / analogs & derivatives*
Inosine Pranobex / therapeutic use*
Lung Neoplasms / therapy*
Lymphocyte Activation
Male
Middle Aged
Rosette Formation
Chemical
Reg. No./Substance:
0/BCG Vaccine; 0/Immunoglobulins; 36703-88-5/Inosine Pranobex; 58-63-9/Inosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Spectrographic determination of zinc in the tissues of adenoma and carcinoma of the prostate.
Next Document:  An animal model for the assessment of microvascular patency.